Phase II Study with Interferon alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Carcinoma. A Trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society

1999

Summary Background: Due to promising results in earlier clinical studies, a confirmatory phase II clinical trial of interferon alpha-2a (IF) and 13-

Keywords:

References

Citations